Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Por um escritor misterioso
Descrição
Regeneron on LinkedIn: Late-Breaking Dupixent® (dupilumab) Data at
Frontiers Severe pediatric asthma therapy: Dupilumab
JCM, Free Full-Text
Frontiers Severe pediatric asthma therapy: Dupilumab
International study supports dupilumab for treatment of moderate
Developments in the Management of Severe Asthma in Children and
Efficacy of dupilumab in asthma.
IL-4/13 blocker successful in treatment of paediatric moderate-to
Dupilumab-improved lung function lasts in children with moderate
Dupilumab in the management of moderate-to-severe asthma: the data